Interleukin-20 (IL-20) plays a part in osteoporosis as well as rheumatoid arthritis, Does this pro-inflammatory cytokine also have a role in oral cancer? Scientists in not only pinpointed a higher expression of IL-20 in clinical oral tumor tissue, but took the additional step to evaluate the therapeutic potential of anti–IL-20 monoclonal antibody.
RESULT: IL-20 and Oral Cancer
Molecular Cancer Research | Nov 15, 2012 (Free abstract. Full text $35)
Cancer patients are known to be at a higher risk for osteoporosis; researchers in Germany set out to determine its prevalence among cancer patients in their country. Measuring bone mineral density in over 1,000 patients at a rehabilitation center, besides confirming a considerably higher-than-general prevalence, they shed light on patient variables associated with this increased risk.
RESULT: Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation
Osteoporosis International (PubMed) | Apr 1, 2012 (FREE FULL TEXT)